A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

Patrick D Williams,David Callanan,Wayne A. Solley,Robert L. Avery,Dante J. Pieramici,Tom Aaberg

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

2012

Patrick D Williams
David Callanan
Wayne A. Solley
Robert L. Avery
Dante J. Pieramici
Tom Aaberg

Purpose This prospective multi-center pilot study compares the use of half-fluence photodynamic therapy combined with ranibizumab with ranibizumab monotherapy for the treatment of neovascular age-related macular degeneration.

Keywords:

Macular degeneration
Ophthalmology
Ranibizumab
Surgery
Physical therapy
Medicine
Photodynamic therapy
Diabetic retinopathy
Combination therapy
Visual acuity
Mann–Whitney U test
Verteporfin
Choroidal neovascularization

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations